MA has restated its disappointment at the health department's failure to consult on the attempt to defer submissions from consideration at the March PBAC meeting following the release of advice that shows officials advised Mark Butler it was "critical" to "mitigate" the reputational risks to the government.
'We are very unhappy that we were not consulted as it is an expectation'
December 3, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Medicines Australia announces appointment of new board chair
March 20, 2025 - - Latest News -
The 'Week in Review Dispatched' Podcast - 21 March
March 20, 2025 - - Podcast -
New NZ approval clears the way for expanded access to cystic fibrosis therapy
March 20, 2025 - - Latest News -
The minister and the US-based industry have a lot in common, including their criticisms of the PBS
March 20, 2025 - - Latest News -
Sigma releases final pre-merger full-year result, confirming impact of CW supply contract
March 20, 2025 - - Latest News -
Stakeholder backing for another PBS co-pay reduction
March 20, 2025 - - Latest News -
If our own government isn't going to do anything, then we can only hope for intervention
March 20, 2025 - - Latest News